Insurance settlement
Final insurance claim received for Nov 29, 2023 fire
Aether Industries received the final insurance settlement on June 5, 2026 for the loss from the Nov 29, 2023 fire, fully offsetting all reported losses.
Bearish
4
Neutral
5
Bullish
5
Bearish
11
Neutral
5
Bullish
30
Bearish
7
Neutral
0
Bullish
25
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Chemicals & Petrochemicals
Specialty Chemicals
15,109 Cr
Moderate Risk
68.8
43.0
2.4
6.2
1,274.20
723.15
Sales CAGR
Profit CAGR
ROE
ROCE

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Aether Industries Ltd (AETHER) is currently trading at 1,135.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aether Industries Limited is a leading specialty chemical manufacturer in India, focusing on producing advanced intermediates and specialty chemicals for diverse sectors such as pharmaceuticals, agrochemicals, and electronics. The company has experienced substantial growth, with a 44% increase in revenue year-on-year for Q3 FY '26, driven by strong performance across its three business models: large-scale manufacturing, contract research and manufacturing services (CRAMS), and exclusive manufacturing. Aether has recently completed significant capacity expansions at Site 3++ and Site 5, positioning itself to meet rising demand, particularly in non-pharma sectors like oil and gas and material sciences. Strategic partnerships with key clients such as Baker Hughes and Milliken are bolstering Aether's market presence and facilitating entry into new markets, highlighting its emphasis on long-term customer relationships. Innovation remains central to Aether's growth strategy, with ongoing R&D expansions and a focus on developing new products and processes that cater to emerging market needs in sectors beyond pharmaceuticals and agrochemicals.
Over the past 52 weeks, Aether Industries Ltd has traded between a low of ₹723.15 and a high of ₹1,274.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aether Industries Ltd has a market capitalization of approximately 15,108.96. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aether Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 68.84 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 15,108.96 Cr, Aether Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aether Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aether Industries Ltd is 68.84. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The fire occurred at an external warehouse at Plot Nos. 24/9 and partially 24/10, Hojiwala Industrial Estate, Sachin, Surat.
The 10,000 crore Biopharma Shakti scheme aims to make India a biopharma hub. Aether, with its strong CRAMS and CEM segments serving the pharma industry, is well-positioned to capture demand for advanced intermediates and biologics-related chemicals.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
